Abstract
Sepsis, a critical condition marked by systemic inflammation, profoundly impacts both innate and adaptive immunity, often resulting in lymphopenia. This immune alteration can spare regulatory T cells (Tregs) but significantly affects other lymphocyte subsets, leading to diminished effector functions, altered cytokine profiles, and metabolic changes. The complexity of sepsis stems not only from its pathophysiology but also from the heterogeneity of patient responses, posing significant challenges in developing universally effective therapies. This review emphasizes the importance of phenotyping in sepsis to enhance patient-specific diagnostic and therapeutic strategies. Phenotyping immune cells, which categorizes patients based on clinical and immunological characteristics, is pivotal for tailoring treatment approaches. Flow cytometry emerges as a crucial tool in this endeavor, offering rapid, low cost and detailed analysis of immune cell populations and their functional states. Indeed, this technology facilitates the understanding of immune dysfunctions in sepsis and contributes to the identification of novel biomarkers. Our review underscores the potential of integrating flow cytometry with omics data, machine learning and clinical observations to refine sepsis management, highlighting the shift towards personalized medicine in critical care. This approach could lead to more precise interventions, improving outcomes in this heterogeneously affected patient population.
Key Points
- Sepsis Definition and Global Impact: Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection, with a high global mortality rate of up to 20%.
- Pathophysiology: Involves systemic inflammation, coagulation, endothelial activation, and microbiome dysbiosis, contributing to organ dysfunction and immunosuppression.
- Immune Phenotyping: Identifies distinct patient profiles based on immune responses, guiding personalized therapeutic approaches and improving diagnostic accuracy.
- Biomarkers: Tools like procalcitonin (PCT) and flow cytometry (e.g., HLA-DR expression) enable early diagnosis, monitor immune status, and predict patient outcomes.
- Immune Dysfunction: Includes delayed neutrophil apoptosis, impaired monocyte antigen presentation, and T and B cell exhaustion, increasing susceptibility to secondary infections.
- Innovative Diagnostics: Flow cytometry facilitates real-time immune cell analysis, while transcriptomics and single-cell RNA sequencing enhance understanding of cellular responses in sepsis.
- Role of Artificial Intelligence: Machine learning aids in phenotyping by analyzing large datasets to identify patterns and predict treatment responses.
- Challenges in Treatment: The heterogeneity of sepsis complicates clinical trials and standardization of therapies, necessitating tailored interventions.
- Personalized Medicine: Tailoring treatments based on patient-specific characteristics, such as immune phenotypes and disease stages, holds promise for improving outcomes.
- Future Directions: Research on metabolic reprogramming in immune cells and innovative therapies, such as immune modulation, will advance sepsis care.
